Talk:Welsh, Carson, Anderson & Stowe/Archives/2011

NPOV
Umm I created the article using the bare minimum info and it was rather NPOV the references were taken out and it looks like some one came in and spammed it out ? M-BMor 00:48, 2 June 2007 (UTC)

NPOV Check
No new discussions on this so nominated for NPOV Check. I created this article as a stub it was taken from a few different places. Immediately after the AFD debate someone came in and expanded it and deleted the references. It went from being as neutral as one could make it drawing on the old refernces to something out of a stock report. Any help in keeping viable content while neutralizing, and referncing would be appreciated. M-BMor 21:40, 12 June 2007 (UTC)


 * since there was no response -- I went ahead and reverted the article back to it's pre - expansion self since it was unsourced NPOV. 'Being Bold" M-BMor 18:00, 14 June 2007 (UTC)

NPOV follow-up
''I’m including an extensive summary of Welsh Carson. All of the information was gathered from the company website and respects a NPOV. I didn’t actually mean to spam out M-BMor’s initial article. Would appreciate some feedback on new article.''

Welsh, Carson, Anderson & Stowe (WCAS) focuses exclusively on two industry sectors: information & business services and healthcare. Established in 1979, WCAS manages over $16 billion of capital. The firm’s strategy is to buy growth businesses in its target industries, partner with best-in-class management and build value through both internal growth and acquisitions.

Today, there are approximately 40 public companies in its two industry sectors with a total market capitalization exceeding $110 billion that can trace their roots to WCAS. In information & business services, portfolio companies include Alliance Data Systems Corporation (ADS), Amdocs Limited (DOX), Dex Media, Inc. which was merged into R.H. Donnelley (RHD), FiServ, Inc. (FISV), SunGard Data Systems, Inc. (SDS) and The BISYS Group, Inc. (BSG). In healthcare, examples of current or former public companies include Quorum Health Group Inc. which was merged into Triad Hospitals, Inc. (TRI), Accredo Health (ACDO), Lincare Holdings Inc. (LNCR), MedCath (MDTH), Select Medical Corporation (SEM), US Oncology (USON), and United Surgical Partners International, Inc. (USPI). The WCAS General Partners combine strategic, operational and financial experience with extensive relationships and expertise within its targeted industries. The General Partners average over 20 years of relevant private equity experience. WCAS industry specialization, combined with many relationships built over 30 years in business, generates strong proprietary deal flow. Over 50% of WCAS investments since 1989 and more recently, over the last five years, were self-generated, proprietary transactions based on the number of transactions and total invested capital. In total, over 95% of WCAS investments have been through either proprietary transactions or limited auctions.

WCAS invests in both large transactions and smaller deals through its buy-and-build strategy. In large buyout situations, the firm looks for opportunities where dislocations in the public market create attractive valuation opportunities. In buy-and-build transactions, the firm also looks for opportunities to add-on to its existing portfolio companies. WCAS portfolio companies have successfully completed over 650 follow-on acquisitions. The firm’s subordinated debt funds also allow WCAS to provide both the equity and the subordinated debt capital required to consummate a transaction.

WCAS focuses on investing with and recruiting highly experienced managers. The firm looks to partner with individuals with the vision and flexibility to adapt their business strategies to the ever-changing economy. Over the last 30 years, WCAS has worked with over 600 senior executives in its two industries. The firm's network of senior operating executives and contacts assists in deal sourcing, due diligence and management recruitment. Given the firm’s industry focus, WCAS also offers a career path to these industry executives as they develop professionally.

WCAS concentrates on improving the operating performance of its portfolio companies. Since 1998, approximately two-thirds of the firm’s investment returns in its two industry sectors have been generated by the operational growth of its portfolio companies.

WCAS generally seeks to invest in companies where it obtains board control although some of its highly successful investments have been in the form of minority stakes. Over 95% of WCAS equity capital since 1989 has been invested in companies which the firm controls. --Kevn-A 17:42, 9 July 2007 (UTC)

•There has been so response so I will place the above article in the Investment & Strategy section.--Kevn-A 16:11, 12 September 2007 (UTC)
 * I understand if you work for the company and want to put out material or whatever -- but wikipedia is NOT a marketing tool this is a rip from company material. I'm leaving it ... but tagging it for NPOV. Find some non welsh carson sources. Maybe link in subsidiaries these are things you can do that will neutralize it and not make it sound like marketing wrote the thing. M-BMor 01:40, 15 September 2007 (UTC)